Tokyo Medical and Dental University is a Japanese national university located in Bunkyō, Tokyo, Japan. Established in 1928, it was the first national school of dentistry in Japan.

During the past decade, Tokyo Medical and Dental University conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 4 clinical trials were completed, i.e. on average, 36.4% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 3 clinical trials were completed. i.e. 75% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Tokyo Medical and Dental University" #1 sponsor was "Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan" with 5 trials, followed by "Boehringer Ingelheim" with 3 trials sponsored, "Alexion" with 2 trials sponsored, "Japan Multinational Trial Organization" with 2 trials sponsored and "Japan Rhabdomyosarcoma Study Group" with 2 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Tokyo Medical and Dental University" #1 collaborator was "Tokyo Medical and Dental University" with 4 trials as a collaborator, "Boehringer Ingelheim" with 1 trials as a collaborator, "Cedars-Sinai Medical Center" with 1 trials as a collaborator, "Columbia University" with 1 trials as a collaborator and "Duke University" with 1 trials as a collaborator. Other collaborators include 10 different institutions and companies that were collaborators in the rest 20 trials.

According to Clinical.Site data, the most researched conditions in "Tokyo Medical and Dental University" are "Colorectal Cancer" (5 trials), "Lung Cancer" (2 trials), "Sarcoma" (2 trials), "ATYPICAL HEMOLYTIC UREMIC SYNDROME (AHUS)" (1 trials) and "Advanced Melanoma" (1 trials). Many other conditions were trialed in "Tokyo Medical and Dental University" in a lesser frequency.

Most popular intervention types in "Tokyo Medical and Dental University" are "Drug" (16 trials), "Procedure" (3 trials), "Biological" (2 trials), "Behavioral" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Nintedanib" (2 trials), "UFT adjuvant chemotherapy" (2 trials), "carboplatin" (2 trials) and "cyclophosphamide" (2 trials). Other intervention names were less common.

The vast majority of trials in "Tokyo Medical and Dental University" are 24 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Tokyo Medical and Dental University". 1 are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Tokyo Medical and Dental University, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Tokyo Medical and Dental University, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".

Tokyo Medical and Dental University has several departments that took part in Clinical trials: "Tokyo Medical and Dental University Hospital" - 95 trials